CD274 and cancer: For example, a phase I/II trial (NCT04432597) evaluated the HPV vaccine PRGN-2009 alone or in combination with bintrafusp alfa, a bifunctional TGF-β “trap”/anti-PD-L1 fusion protein in patients with HPV-associated cancers.